Exosome Diagnostics And Therapeutics Market Trends
Great potential for minimally invasive surgeries:
- Exosomes are prevalent in various biofluids, including blood, urine, and cerebrospinal fluid, making them conveniently accessible for diagnostic purposes employing minimally invasive therapies. Exosome-based diagnostics are non-invasive, which has several benefits over traditional tissue biopsy methods, which can be more invasive and harmful. Exosomes can be used as liquid biopsy tools to track the progression of a disease and its response to treatment in real-time without requiring repeated tissue samples.
- This minimally invasive method improves patient comfort and compliance and allows more frequent monitoring, timely interventions, and customized treatment regimens. The potential for liquid biopsy and less invasive diagnostics using exosomes drives much interest and investment in the exosome diagnostics and therapies sector. With these technologies, patients may experience improved patient outcomes, personalized medicine, and early sickness detection.